Specialist Updates 
Oncology

Patients on checkpoint inhibitors may need bone screening, endocrinologist suggests

A new Australian study shows an association between immune checkpoint inhibitor therapy and osteoporosis.
0
5 September 2024
Save

Emerging evidence shows an association between immune checkpoint inhibitor therapy and osteoporosis, with the agents linked to increased fracture risk in cancer patients.

The latest research, in BMJ Oncology, found that the rate of major osteoporotic fracture increased in patients with melanoma early after initiation of immunotherapy, such as pembrolizumab.

Report

Harassment or bullying behavior
Contains mature or sensitive content
Contains misleading or false information
Contains abusive or derogatory content
Content that breaches the privacy of other individuals
Contains spam, fake content or potential malware

Block Member?

Please confirm you want to block this member.

You will no longer be able to:

  • See blocked member's posts
  • Mention this member in posts
  • Message this member
  • Add this member as a connection

Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

Report

You have already reported this .